GH/STAT5 signaling during the growth period in livers of mice overexpressing GH

• Published in: Journal of molecular endocrinology Vol. 54; no. 2; pp. 171 - 184
• Main Authors: Martinez, Carolina S, Piazza, Verónica G, Díaz, María E, Boparai, Ravneet K, Arum, Oge, Ramírez, María C, González, Lorena, Becú-Villalobos, Damasia, Bartke, Andrzej, Turyn, Daniel, Miquet, Johanna G, Sotelo, Ana I
• Format: Journal Article
• Language: English
• Published: England Bioscientifica Ltd 01-04-2015
• Subjects: Animals; Gene Expression Regulation, Developmental; Growth Hormone - metabolism; Insulin-Like Growth Factor I - metabolism; Liver - growth & development; Liver - metabolism; Mice, Inbred C57BL; Mice, Transgenic; Phosphorylation; Receptors, Somatotropin - genetics; Receptors, Somatotropin - metabolism; Signal Transduction; STAT5 Transcription Factor - metabolism; Suppressor of Cytokine Signaling Proteins - genetics; Suppressor of Cytokine Signaling Proteins - metabolism; GH-overexpressing mice; STAT5; growth; GH signaling; liver
• ISSN: 0952-5041; 1479-6813
• DOI: 10.1530/JME-14-0262

GH/STAT5 signaling is desensitized in the liver in adult transgenic mice overexpressing GH; however, these animals present greater body size. To assess whether the STAT5 pathway is active during the growth period in the liver in these animals, and how signaling modulators participate in this process, growing transgenic mice and normal siblings were evaluated. STAT5 does not respond to an acute GH-stimulus, but displays higher basal phosphorylation in the livers of growing GH-overexpressing mice. GH receptor and the positive modulators glucocorticoid receptor and HNF1 display greater abundance in transgenic animals, supporting the activity of STAT5. The negative modulators cytokine-induced suppressor and PTP1B are increased in GH-overexpressing mice. The suppressors SOCS2 and SOCS3 exhibit higher mRNA levels in transgenic mice but lower protein content, indicating that they are being actively degraded. Therefore, STAT5 signaling is increased in the liver in GH-transgenic mice during the growth period, with a balance between positive and negative effectors resulting in accelerated but controlled growth.